Effects of Selenium and/or N-Acetyl-Cysteine Supplementation on Nonthyroidal Illness Syndrome in Hemodialysis Patients: A Factorial Randomized Controlled Trial.

Elham Shahreki,Mahmoud Ali Kaykhaei,Zahra Mosallanezhad, Zahra Adineh,Ali Mohammad Mokhtari,Mahdi Mohammadi,Razieh Hosseini,Aliyeh Bazi

Pharmacology（2022）

引用 1|浏览3

暂无评分

摘要

This trial showed that Se and/or NAC exert beneficial effects on rT3 levels in HPs. However, long-term clinical trials with a larger sample size using more appropriate biomarkers are recommended to evaluate the efficacy and safety of Se and/or NAC in HPs.

查看译文

关键词

Hemodialysis patients,N-acetyl-cysteine,Nonthyroidal illness syndrome,Selenium

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要